Going to #USCAP2025? Join #Agilent as we explore Gastric Cancer and PD-L1 Heterogeneity Across the Patient Journey ?? ?? Key Questions: Does PD-L1 expression in lymph nodes reliably predict patient outcome? How can tumor heterogeneity be managed to ensure the most accurate diagnosis? How does treatment with chemotherapy or immunotherapy affect PD-L1 expression? Understanding the variability in PD-L1 expression is crucial for tailoring effective patient treatment. Join the conversation! ?? Learn more: https://lnkd.in/drmzTm8T ??? Monday, March 24 ?? 5:30 PM ??Seminar Room 3 #CancerResearch #Immunotherapy D0128208_1.00
Agilent Dako Pathology Solutions
生物技术研究
Santa Clara，California 5,819 位关注者
Agilent delivers trusted answers to our customers’ critical questions and challenges.
关于我们
Agilent is a global leader in life sciences, diagnostics, and applied chemical markets providing laboratories worldwide with instruments, services, consumables, applications, and expertise, enabling customers to gain the insights they seek. Agilent's expertise and trusted collaboration give them the highest confidence in our solutions. Our high-quality diagnostic antibodies, reagents, instruments, software, and expertise help pathology laboratories make accurate tissue-based cancer diagnoses and determine the most effective treatment for cancer patients. We are proud to be a renowned provider of complete pathology solutions, as highlighted by our Agilent Dako portfolio, and trusted by clinical laboratories around the world in the fight against cancer. By establishing lasting partnerships worldwide with partnering companies, ranging from large multinationals to smaller manufacturers and commercial laboratories, we support the fields of in vitro diagnostics, biotechnology, and pharmaceuticals. Agilent’s strong track record in developing, validating, and commercializing companion diagnostics, in partnership with pharmaceutical companies, positions us as a global leader in CDx and precision oncology.
- 网站
-
https://www.agilent.com
Agilent Dako Pathology Solutions的外部链接
- 所属行业
- 生物技术研究
- 规模
- 超过 10,001 人
- 总部
- Santa Clara，California
- 创立
- 1999
- 领域
- Anatomic Pathology、Histology、Histopathology、Tissue Diagnostics、Staining Solutions、in-vitro和Companion Diagnostics
动态
-
?? Join Us at #USCAP 2025! ?? Agilent is excited to announce our upcoming seminar: Advancing Diagnostics: Cutting-Edge Innovations and Insights in Digital Pathology. Don’t miss this opportunity to connect with industry leaders and explore how digital pathology is transforming diagnostics. Learn more: https://lnkd.in/dJfjGJxp ??? Monday, March 24 ?? 12:00 PM ??Seminar Room 4 D0128203_1.00
-
-
Join #Agilent for an exclusive evening of networking and engaging discussions with industry leaders at Ocean Prime in Boston! Meet our digital pathology partners Hamamatsu, Proscia, Visiopharm, and PathAI, who will be there to answer your most pressing questions. This is your chance to connect with our leadership, meet fellow experts in digital pathology, and delve into cutting-edge topics in the field. ?? Cocktails and small plates provided. ???Sunday, March 23, 2025?? ?? 7:00 PM - 9:00 PM?? ??Ocean Prime Don't miss out on this unique opportunity! RSVP here: https://lnkd.in/eGE7pbaX #DigitalPathology #USCAP2025 #Boston D0129010_1.00
-
Achieving quality in histopathology is a continuous journey, with pre-analytical steps playing a pivotal role in the accuracy of PD-L1 IHC 22C3 pharmDx testing. Join us for an insightful live webinar on “Enhancing Histopathology Quality: The Critical Role of Pre-Analytical Steps and Controls in PD-L1 IHC 22C3 pharmDx Testing” presented by Sachin Gupta PhD, Product Specialist at Agilent. Don’t miss this opportunity to enhance your understanding and improve your lab’s performance! Date: Thursday March 27, 2025 Time: 2.00 pm IST | 4.30 pm SGT https://lnkd.in/dqnPCbWs #Dako #Agilent #PD-L1 #Preanalytical #IHC #22C3
-
-
Designed with you in mind - Agilent Dako Omnis features a user-friendly interface, flexibility to run tests as needed, and smart alerts to keep your lab running smoothly. Visit link to watch the full video. https://lnkd.in/eTrshxbM #LabTech #ClinicalPathology #DakoOmnis D0125178_1.00 This product is not available for purchase by the general public.
-
Don’t miss our exciting live webinar on the?“Enhancing Histopathology Quality: The Critical Role of Pre-Analytical Steps and Controls in PD-L1 IHC 22C3 pharmDx Testing” presented by?Sachin Gupta PhD, Product Specialist at?Agilent. This webinar will explore the critical importance of these pre-analytical steps, emphasizing their impact on test outcomes. We will also discuss the significance of implementing robust controls to ensure reliable and reproducible results. Join us to learn from an expert and elevate your understanding of this crucial aspect of histopathology! Date: Thursday March 27, 2025 Time: 2.00 pm IST | 4.30 pm SGT https://lnkd.in/dqnPCbWs #Agilent #Dako #PreAnalytical #PharmDxTesting #PDL1#IHC #22C3
-
-
Join #Agilent for a three-hour training on February 19th to improve your CPS technique for scoring PD-L1 IHC 22C3 pharmDx stained Slides. ?? Register TODAY ? https://lnkd.in/eXaS9r2w D0125556_1.00
-
-
Join #Agilent for a three-hour training on January 23rd or February 19th to improve your CPS technique for scoring PD-L1 IHC 22C3 pharmDx stained Slides. ?? Register TODAY ? https://lnkd.in/eXaS9r2w D0125556_1.00
-
-
Installed worldwide. Pathology labs across the globe rely on Agilent Dako Omnis for rapid and reliable staining results. Join the community of labs that choose Dako Omnis to meet their complex needs. Explore why Dako Omnis is the preferred solution for advanced tissue staining. https://bit.ly/4i2Dt1X #DakoOmnis #Pathology #Immunohistochemistry #TrustedPerformance D0120954 1.00 This product is not available for purchase by the general public.
-
Watch Prof. Bharat Jasani, Emeritus Professor at Cardiff University, demonstrate PD-L1 scoring in two cervical cancer cases. With extensive expertise in PD-L1 as a predictive marker for immune checkpoint therapy, Prof Jasani walks through CPS determination in this insightful video. See more here: https://bit.ly/49u6eAy D0121183_1.00